These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22474125)

  • 1. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
    Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
    Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds.
    Jozic I; Abujamra BA; Elliott MH; Wikramanayake TC; Marjanovic J; Stone RC; Head CR; Pastar I; Kirsner RS; Andreopoulos FM; Musi JP; Tomic-Canic M
    Commun Biol; 2021 Jun; 4(1):757. PubMed ID: 34145387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo.
    Sago CD; Lokugamage MP; Lando GN; Djeddar N; Shah NN; Syed C; Bryksin AV; Dahlman JE
    Nano Lett; 2018 Dec; 18(12):7590-7600. PubMed ID: 30216729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SREBP1 regulates
    Li J; Shen H; Owens GK; Guo LW
    Mol Ther Nucleic Acids; 2022 Jun; 28():892-909. PubMed ID: 35694209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of caveolin-1 in skin diseases.
    Takamura N; Yamaguchi Y
    Front Immunol; 2022; 13():1035451. PubMed ID: 36532050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma.
    Fu P; Chen F; Pan Q; Zhao X; Zhao C; Cho WC; Chen H
    Onco Targets Ther; 2017; 10():819-835. PubMed ID: 28243118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic assessment and management of early esophageal adenocarcinoma.
    Hammoud GM; Hammad H; Ibdah JA
    World J Gastrointest Oncol; 2014 Aug; 6(8):275-88. PubMed ID: 25132925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis.
    Jin Z; Wang L; Cao Z; Cheng Y; Gao Y; Feng X; Chen S; Yu H; Wu W; Zhao Z; Dong M; Zhang X; Liu J; Fan X; Mori Y; Meltzer SJ
    BMC Cancer; 2014 May; 14():345. PubMed ID: 24885118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
    Yang L; Francois F; Pei Z
    Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein.
    Prade E; Tobiasch M; Hitkova I; Schäffer I; Lian F; Xing X; Tänzer M; Rauser S; Walch A; Feith M; Post S; Röcken C; Schmid RM; Ebert MP; Burgermeister E
    Mol Endocrinol; 2012 May; 26(5):819-32. PubMed ID: 22474125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.
    Hitkova I; Yuan G; Anderl F; Gerhard M; Kirchner T; Reu S; Röcken C; Schäfer C; Schmid RM; Vogelmann R; Ebert MP; Burgermeister E
    PLoS Pathog; 2013; 9(4):e1003251. PubMed ID: 23592983
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.